Suchergebnisse - "Hart, Robert G"

PubPharm (74)

1

Effect of the Factor XIa Inhibitor Asundexian According to Baseline Infarct Pattern and on MRI Covert Infarct Outcomes

enthalten in: Stroke | 2024

von Smith, E. | Shoamanesh, A. | Xu, L. | +116

2

Comparison of Investigator-Reported vs Centrally Adjudicated Major Adverse Cardiac Events : A Secondary Analysis of the COMPASS Trial

enthalten in: JAMA network open | 2022

von Gaba, P. | Bhatt, D. | Dagenais, G. | +59

3

Factor XIa inhibition with asundexian after acute non-cardioembolic ischaemic stroke (PACIFIC-Stroke) : an international, randomised, double-blind, placebo-controlled, phase 2b trial

enthalten in: Lancet (London, England) | 2022

von Shoamanesh, A. | Mundl, H. | Smith, E. | +32

4

Rivaroxaban versus aspirin for prevention of covert brain infarcts in patients with embolic stroke of undetermined source : NAVIGATE ESUS MRI substudy

enthalten in: International journal of stroke : official journal of the International Stroke Society | 2022

von Sharma, M. | Smith, E. | Pearce, L. | +22

5

Rivaroxaban versus aspirin on functional and cognitive outcomes after embolic stroke of undetermined source : NAVIGATE ESUS trial

enthalten in: Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association | 2022

von Bosch, J. | Pearce, L. | Sharma, M. | +7

6

Antihypertensives and Statin Therapy for Primary Stroke Prevention : A Secondary Analysis of the HOPE-3 Trial

enthalten in: Stroke | 2021

von Bosch, J. | Lonn, E. | Dagenais, G. | +17

ErratumIn: Stroke. 2021 Aug;52(8):e526. - PMID 34310183

7

Mortality Benefit of Rivaroxaban Plus Aspirin in Patients With Chronic Coronary or Peripheral Artery Disease

enthalten in: Journal of the American College of Cardiology | 2021

von Eikelboom, J. | Bhatt, D. | Fox, K. | +15

CommentIn: J Am Coll Cardiol. 2021 Jul 6;78(1):24-26. - PMID 34210410

8

Microbleeds and the Effect of Anticoagulation in Patients With Embolic Stroke of Undetermined Source : An Exploratory Analysis of the NAVIGATE ESUS Randomized Clinical Trial

enthalten in: JAMA neurology | 2021

von Shoamanesh, A. | Hart, R. | Connolly, S. | +17

CommentIn: JAMA Neurol. 2021 Jan 1;78(1):9-10. - PMID 33074292

9

Characteristics of Recurrent Ischemic Stroke After Embolic Stroke of Undetermined Source : Secondary Analysis of a Randomized Clinical Trial

enthalten in: JAMA neurology | 2020

von Veltkamp, R. | Pearce, L. | Korompoki, E. | +19

ErratumIn: JAMA Neurol. 2020 Oct 1;77(10):1322. - PMID 32897298

10

Intracranial and systemic atherosclerosis in the NAVIGATE ESUS trial : Recurrent stroke risk and response to antithrombotic therapy

enthalten in: Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association | 2020

von Ameriso, S. | Amarenco, P. | Pearce, L. | +16

1
2
3
4
5
6
7
8
Nächster »
[8]